-
Drug-Sensitized Yeast Enables Sensitive Discovery of mTOR In
2026-05-30
This study introduces a drug-sensitized yeast platform that dramatically increases sensitivity for detecting mTOR/TOR inhibitors, streamlining drug discovery in aging and cancer research. The system reliably distinguishes true TOR pathway inhibitors from unrelated compounds, offering a robust, cost-effective preclinical screening tool.
-
Nitrocefin: Chromogenic Cephalosporin Substrate in Resistanc
2026-05-29
Nitrocefin enables rapid, visual, and quantitative β-lactamase detection, streamlining the profiling of antibiotic-resistant bacteria. This article translates the latest research on resistant pathogens and enzymatic assays into actionable protocols and optimization strategies for laboratory scientists.
-
Ruxolitinib Phosphate (INCB018424): Selective JAK1/JAK2 Inhi
2026-05-29
Ruxolitinib phosphate (INCB018424) is a potent, selective inhibitor of JAK1 and JAK2, enabling robust and reproducible JAK/STAT pathway modulation in cellular models. Its high solubility and specificity make it essential for research in autoimmune and neoplastic diseases. Recent studies highlight its capacity to induce apoptosis and pyroptosis in anaplastic thyroid cancer cells via suppression of DRP1-mediated mitochondrial fission.
-
HyperFluor™ 594 Goat Anti-Rabbit IgG: Evidence and Protocols
2026-05-28
The HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody is a rigorously affinity-purified, fluorescently labeled secondary antibody suited for sensitive immunodetection in ICC, IHC, flow cytometry, and ELISA. Its excitation/emission maxima (590/617 nm) enable multiplexed imaging, while its validated specificity for rabbit IgG ensures robust results in cell biology and immunopathology research.
-
Maraviroc (UK-427857): Advanced Workflows in HIV and Neuroin
2026-05-28
Maraviroc (UK-427857) is more than a CCR5 antagonist: it empowers researchers to dissect HIV-1 entry and neuroinflammatory mechanisms in both virology and neuroscience. This guide translates the latest evidence and expert protocols into actionable workflows, highlighting APExBIO's Maraviroc as a trusted tool for reproducibility and advanced application.
-
Myriocin: Applied Workflows for Sphingolipid Metabolism Rese
2026-05-27
Myriocin, a gold-standard serine palmitoyltransferase inhibitor from APExBIO, enables precise modulation of sphingolipid biosynthesis for advanced metabolic, oncology, and immunology studies. This guide translates recent in vivo breakthroughs into step-by-step protocols and troubleshooting strategies for maximizing experimental clarity and reproducibility.
-
Substance P: Precision Tools for Tachykinin Neuropeptide Res
2026-05-27
Substance P, an archetype tachykinin neuropeptide from APExBIO, unlocks advanced workflows in pain transmission, inflammation, and immune modulation research. Discover optimized protocols, troubleshooting insights, and the impact of next-generation spectral analytics for robust, reproducible results.
-
Substance P: Applied Workflows for Pain and Inflammation Res
2026-05-26
Harnessing APExBIO's high-purity Substance P enables precise and reproducible investigations into pain transmission, inflammation, and immune response modulation. This guide details optimized protocols, spectral troubleshooting, and translational insights for leveraging this tachykinin neuropeptide in advanced experimental settings.
-
Clodronate Liposomes: Precision Tools for Macrophage Subset
2026-05-26
Explore how Clodronate Liposomes enable targeted in vivo macrophage depletion and empower functional dissection of immune cell subsets. This article reveals advanced mechanistic insights and practical assay strategies, setting it apart from scenario-driven or translational guides.
-
Optimizing Wnt Pathway Assays with LGK-974 (Porcupine Inhibi
2026-05-25
This article presents scenario-driven best practices for scientists using LGK-974 (Porcupine Inhibitor, SKU B2307) to interrogate Wnt signaling with high specificity and reproducibility. Grounded in peer-reviewed data and practical lab workflows, it addresses real-world challenges in cell viability and Wnt pathway assays, highlighting APExBIO’s LGK-974 as a robust solution for consistent and interpretable results.
-
Palonosetron Hydrochloride and CINV: Clinical Advances and I
2026-05-25
The reference study offers a comprehensive evaluation of palonosetron hydrochloride as a 5-HT3 receptor antagonist for preventing chemotherapy-induced nausea and vomiting (CINV). Its notable pharmacokinetic and pharmacodynamic properties, including a long half-life and allosteric receptor binding, position it as a significant advance over earlier antiemetics, informing antiemetic protocol optimization and the role of adjunct corticosteroids.
-
Protease Inhibitor Cocktail EDTA-Free, 100X in DMSO: Practic
2026-05-24
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) addresses the challenge of proteolytic degradation during protein extraction, especially when downstream assays require preservation of divalent cations. It is ideal for workflows such as Western blotting, co-immunoprecipitation, and phosphorylation analysis, but is not intended for applications where EDTA-based inhibition of metalloproteases is essential.
-
Prednisone: Strategic Leverage in Translational Immunology
2026-05-23
Explore how APExBIO’s Prednisone empowers researchers to model immunosuppression and apoptosis with unprecedented mechanistic and translational precision. This article blends foundational corticosteroid biology, state-of-the-art validation strategies, and strategic guidance—bridging the gap between preclinical models and clinical relevance.
-
Amorolfine Hydrochloride: Reliable Antifungal Reagent for Re
2026-05-22
This article delivers a scenario-driven, evidence-based guide to optimizing cell-based antifungal assays using Amorolfine Hydrochloride (SKU B2077). It highlights practical solutions to common lab challenges, emphasizes reproducibility and data integrity, and compares supplier reliability. Researchers will find actionable insight into protocol optimization, data interpretation, and vendor selection for advanced fungal infection research.
-
Paeoniflorin Modulates Tmem176b+ Macrophage Polarization in
2026-05-22
This study demonstrates that paeoniflorin attenuates hepatic ischemia-reperfusion (I/R) injury by promoting Tmem176b+ macrophage polarization from pro-inflammatory (M1-like) to reparative (M2-like) states. Single-cell RNA sequencing and functional depletion experiments reveal that Tmem176b+ macrophages are critical mediators of paeoniflorin's protective effects, providing new avenues for targeted immune modulation in liver transplantation.